SCHEMBL3660712

SCHEMBL3660712

CC(=O)[C@H]1C(=O)CCN1C(=O)O

nearest known ligand 0.39

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.32
MAPT P10636 1/20 0.32
POLB P06746 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16733331 0.83 ACE (0.33)
SCHEMBL2869309 0.83 ACE (0.33)
SCHEMBL17495292 0.75 MAPK1 (0.39) LMNAMAPT
SCHEMBL12151736 0.75 LMNA (0.33) LMNAMAPT
SCHEMBL17510318 0.75 LMNA (0.33) LMNAMAPT
SCHEMBL3274371 0.75 LMNA (0.33) LMNAMAPT
SCHEMBL3278691 0.72 L3MBTL1 (0.35) MAPT
SCHEMBL3275456 0.71 AKR1C4 (0.31)
SCHEMBL2487318 0.71 LMNA (0.34) LMNAMAPTPOLB
SCHEMBL5625371 0.71 AKR1C4 (0.31)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2190428-A1 HETEROCYCLIC COMPOUNDS AS DIPEPTIDYL PEPTIDASE-IV INHIBITORS FOR THE TREATMENT OR PREVENTION OF DIABETES Merck Sharp & Dohme Corp. (US) 2010-06-02 EP disclosed
WO-2009025784-A1 HETEROCYCLIC COMPOUNDS AS DIPEPTIDYL PEPTIDASE-IV INHIBITORS FOR THE TREATMENT OR PREVENTION OF DIABETES MERCK & CO., INC. (US) 2009-02-26 WO disclosed